SUMMARY. The hypotension and bradycardia observed after intravenous injection of dextran sulf ate in rabbits was prevented by prior depletion of circulating platelets, but was not prevented by depletion of the third component of complement or Hageman factor. Dextran sulfate injection caused immediate thrombocytopenia with temporary localization of platelets within lungs. Morphological analysis revealed platelet aggregates in lung capillaries. The platelets had changed shape and were in the process of degranulating. Serotonin and histamine levels in blood increased approximately 5-fold and 7-fold, respectively,.after dextran sulfate injection. The cardiovascular events following dextran sulfate injection were mimicked by intravenous serotonin but not by intravenous histamine injection, although a combination of serotonin and histamine reproduced the pattern of blood pressure changes better than did either agent alone. Quantification of platelets trapped in lung revealed that the potential release of serotonin from trapped platelets could account for the rise in plasma serotonin concentration and the hemodynamic changes observed. Both the dextran sulfate-induced cardiovascular effects and serotonin-induced hypotension were markedly diminished by cutting vagus and depressor nerves, and were virtually abolished by carotid ligation in addition to nerve section. These results support the concept that platelet activation within rabbit lungs may cause hypotension via serotonin-induced chemoreflexes. (Circ Res 57: 262-277, 1985) 
ACUTE hypotension follows intravenous injections of numerous substances. This abrupt decrease in blood pressure may be mediated by direct effects of drugs on resistance vessels. On the other hand, similar events may be initiated by specific antigen recognition leading to activation of mast cells and basophils (anaphylaxis), or they may be induced by non-allergic reactions such as are seen after injection of contrast media (anaphylactoid). The precise chain of events responsible for acute hypotension in the latter situation is not fully understood, although histamine is thought to be an important mediator. In the rabbit model of IgE-anaphylaxis, acute hypotension has been shown to be platelet-dependent (Benveniste et al., 1972; Pinckard et al, 1977) and secondary to release of platelet-activating factor from basophils (McManus et al., 1979) . In this study (also in the rabbit), the contributions of different mediator systems activated after intravenous injection of an anionic heparin-like polymer, dextran sulfate, have been analyzed. The results of this study show that a powerful chemoreflex mediated by platelet serotonin was responsible for causing the acute hypotension. A similar sequence of events could contribute to the anaphylactoid response, including acute hypotension, sometimes seen in humans immediately after injection of various substances, or after the hookup of extracorporeal circulation systems.
Methods
Male New Zealand white rabbits weighing 2-3 kg were used. They were fasted for 24-48 hours before study, although they had free access to water. Arterial pressure measurements were made directly with catheters inserted under local anesthetic into the femoral artery (Intramedic PE50). Infusions and venous pressure measurements were made via a catheter inserted into the femoral vein (Intramedic PE50). Both catheters were introduced to the approximate level of the diaphragm. For infusion into the right ventricle, the venous catheter was advanced until pressure recordings showed appropriate right ventricular pressure changes. In each case, the position of the catheter subsequently was checked by autopsy at the end of the study. Catheters sometimes were inserted the day prior to study. In this case, the catheters were filled with saline, knotted, and buried under the skin, with the skin closed by suture. The following day, access to catheters was obtained by cutting the sutures. For measurements of arterial pressure, rabbits were placed supine on boards and were secured by cords to the limbs. Since the response to dextran sulfate was not affected by barbiturate anesthesia, many of the studies described were performed under a barbiturate general anesthetic (sodium pentobarbitone, 10-15 mg/kg) administered as required via a catheter in the marginal ear vein). Arterial and venous pressure was measured with a Statham pressure transducer (P37B) and a Statham SP1400 blood pressure monitor. For most studies, the data were expressed as the mean arterial pressure, which was either recorded directly from the monitor or was calculated (diastolic plus one-third of the difference between systolic and diastolic pressure) from the printout that had been calibrated previously.
Platelet Depletion
Sheep antirabbit platelet antiserum, which was kindly supplied by Dr. C. Cochrane, Department of Immunopathology, Research Institute of Scripps Clinic, was used to deplete rabbits of circulating platelets. Preliminary studies snowed that intraperitoneal injection of 5 ml of antiserum resulted in a decrease in circulating platelet levels to less than 10% of the starting level within 1 hour, and that this extent of platelet depletion lasted for at least 5 hours. Furthermore, in association with the depletion of platelets, there were no significant changes in circulating neutrophil leukocytes or monocytes in the pilot study.
For the platelet-depletion studies described, three rabbits were depleted by intraperitoneal injection of 5 ml of sheep antirabbit platelet antiserum. Three hours after administration of the antiserum, the platelet count had fallen to 3.2, 9.8, and 4.8% of initial values. Three control rabbits that received non-immune serum had platelet counts of 89.4, 109.4, and 110.1% of initial values. Counts for mononuclear cells were 66.7, 97.6, and 75.6% in the platelet-depleted animals compared with 97.0, 76.7, and 160% in the control animals 3 hours after antiserum injection. Neutrophil counts were 79.3, 83.5, and 72.3% in platelet-depleted rabbits compared with 75.4, 120.0, and 268% in control animals. The third control rabbit had a marked increase in both blood mononuclear and neutrophil levels in the 3-hour period after non-immune serum injection. Otherwise, values obtained with the control animals were comparable to those of the experimental rabbits. Dextran sulfate (20 mg/kg intravenously) was administered to both groups of animals 3 hours after they had received either antiplatelet antiserum or non-immune globulin.
Platelet Distribution Study

M
Cr-Labeled platelets (0.9 /xCi) were injected into each of six rabbits 18 hours before study. Duxtran sulfate (DxSO,, 20 mg/kg in 0.15 M NaCl) was injected into three rabbits, while three rabbits received 0.15 M NaCl alone. One minute after DxSO 4 (or saline) injection, each rabbit received 12S I-albumin (1 /iCi) injected in 5 ml 0.15 M NaCl into the inferior vena cava via a femoral vein catheter. After another minute, rabbits were killed by intravenous injection of sodium pentobarbitone (120 mg). Blood was taken before injection of DxSO 4 for counting M Cr and platelets. After sacrifice, tissues (lungs, heart, liver, spleen, kidneys, fat, muscle, skin, stomach, and intestine) were removed, weighed, and counted for radioactivity. With the ratio of M Cr to 123 I in the blood and the amount of 12J I in each organ known, it was possible to calculate the expected "Cr in each organ based on that organ's blood content. This calculated value was subtracted from the observed value and corrected for organ weight to give the value in Table 1 . The high levels in liver and spleen represent platelet destruction in the 18 hours between "Cr-platelet injection and death of the animal, and are similar in the DxSO 4 -treated and control animals. The major^ difference between the groups of animals was in the lung. Since the blood platelet counts before injection of DxSO 4 were known, and corresponded to a Cr count in the blood, it was possible to calculate the excess number of platelets per gram of lung present in the DxSO 4 -treated animals. As the total lung weights for each animal were also measured, it was possible to estimate the total number of platelets trapped in the lung 2 minutes after DxSO 4 injection.
Morphological Studies
Lung samples for transmission electron microscopic (TEM) and light microscopic (LM) evaluation were obtained from six New Zealand white rabbits. Rabbits were killed 2, 3, 20, and 30 minutes after DxSO 4 injection. Two rabbits were used as controls. For control and 2-or 3-minute studies rabbits were anesthetized with sodium pentobarbitone, then given either normal saline (control) or DxSO 4 (20 mg/kg) intravenously. For the 20-and 30-minute studies DxSO4 was injected prior to anesthesia. Rabbits were killed by sodium pentobarbital injection (170 mg) given intravenously over 30 seconds. The thoracic cavity was immediately exposed. The trachea was canulated, and the lung was inflated in situ with approximately 50 ml of cold 4% glutaraldehyde buffered with 0.1 M cacodylate, pH 7.3, (300 mOsm/liter). The entire lung was excised and placed in cold 4% buffered glutaraldehyde. Fifteen minutes later random sections (1 mm 3 ) were cut for TEM evaluation, and adjoining tissue was taken for LM histology. The lung pieces for TEM were fixed overnight at 4°C in the buffered glutaraldehyde, then rinsed well with 0.1 M cacodylate buffer The samples were postfixed in 2% OsO, (buffered with 0.1 M cacodylate, pH 7.3) for 1 hr at 4°C, dehydrated in graded alcohols to propylene oxide, infiltrated with epon/araldite:propylene oxide mixture, embedded in epon/araldite resin, and polymerized overnight at 65°C. Ultra-thin sections were cut, stained with 2% uranyl acetate and lead citrate, and examined on a Philips 201 transmission electron microscope.
Plasma Serotonin Measurement
Blood (1.8 ml) was drawn from a femoral arterial catheter and immediately added to 200 ul of acid-citratedextrose anticoagulant. After being gently mixed, 1 ml of blood was added to 200 fi\ of EDTA (4 mg/ml) in a polypropylene conical centrifuge tube and centrifuged on a Beckman microfuge (Beckman Instruments, Inc.). Plasma was removed and stored frozen at -30°C. Measurement of serotonin was performed by the method described by Parbtani and Cameron (1979) . This method involves the formation of a fluorophore by serotonin and O-phthaldialdehyde (OPT) under acid conditions. Fluorescence emitted at 475 nM while exciting at 360 nM was measured on an SF 330 spectrofluorometer (Varian Instruments). This method assumes that the major substance in plasma which will fluoresce under these conditions is serotonin. In control studies, DxSO 4 and histamine did not induce fluorescence, and the spectra for serotonin and plasma were similar, indicating that serotonin was the major substance giving rise to fluorescence under the conditions of study. The recovery of serotonin added back to platelet poor Results are expressed as mean ± SEM.
• P < 0 . 0 5 .
Circulation Research/Vol. 57, No. 2, August 1985 plasma was 71%. The limit of sensitivity of the assay was 10 ng/ml (n = 10). The coefficient of variation was 19% (standard deviation X 100 divided by the mean for 10 measurements). To confirm that serotonin was present in plasma, we also, performed high pressure liquid chromatographic (HPLC) analyses of plasma. These analyses were performed on plasma samples from which the protein had been precipitated with trichloroacetic acid. Twenty microliters of trichloroacetic acid (200 g/100 ml) were added to 200 n\ of plasma and allowed to stand in ice for 30 minutes. The sample was centrifuged, and the supernatant was washed with 500 til of diethyl ether. One hundred microliters of sample were applied to a 30 cm X 4 mm MCH 10 reverse phase column (Varian Instruments) and run on an LC 5000 liquid chromatograph (Varian Instruments). The effluent was monitored at 210 run with a variable wavelength UV 50 detector (Varian Instruments). The buffer consisted of 12% acetonitrile containing 0.1% trifluoroacetic acid throughout. The retention time for serotonin was 9.5 minutes.
Plasma Histamine Measurement
Blood was drawn into anti-coagulant, centrifuged, separated as described for serotonin, and then stored at -70°C for assay. A specific histamine assay using [ 3 H]-Sadenosyl methionine to methylate histamine in the presence of histamine N-methyltransferase, as described by Dyer et al. (1982) , was used. Briefly, the isotope, enzyme, and sample were incubated at 37°C for 1.5 hours. The reaction was stopped by the addition of perchloric acid. After centrifugation, the supernatant was extracted with chloroform. The extracted material was dried under nitrogen," then reconstituted in chloroform and spiked with unlabeled methyl histamine. This mixture was spotted onto thin layer plates and run in a 95:10 (vol/vol) acetone:ammonium hydroxide system. The plates then were dried in an oven, sprayed with O-phthaldialdehyde, redried, and the spots were visualized by ultraviolet light. The spots were scraped off into a scintillation vial, extracted with 0.1 N HC1, and, after addition of sdntillant, were counted on a /S-counter. All samples were done in duplicate and were compared to a standard curve constructed by adding known amounts of histamine to dialyzed rabbit plasma. The coefficient of variation of the assay was 32%, and the limit of sensitivity was 200 pg/ ml.
Nerve Section and Carotid Ligation
In more than 20 rabbits studied in which femoral artery catheters had been placed under local anesthetic (2% lidocaine), and in more than 30 rabbits that received sodium pentobarbitone anesthesia, we noted no difference in cardiovascular response to serotonin, histamine, or DxSO 4 injection. Therefore, to minimize discomfort to animals, we studied the rabbits under sodium pentobarbitone general anesthesia (10-15 mg/kg, intravenously, as required). Femoral arterial and venous catheters were placed in each rabbit to approximately the level of the diaphragm. A midline incision was made in the skin from the jaw to the manubrium, and the pretracheal fascia was split in the midline. Muscles lying in front of the trachea were cut, and a tracheal cannula (5-cm portion of a 2-ml plastic pipette) was secured with a silk thread. A longitudinal incision through the strap muscles was made 0.5 cm from the midline according to the method of Kremer et al. (1933) . The carotid artery, vagus, and depressor nerves weTe identified and isolated by gentle blunt dissection.
For the study described (Figs. 12 and 13), both vagus and depressor nerves were cut on both sides in three rabbits. In the control animals, the nerves were identified and isolated but were not cut (sham-operated). After nerve section, there was an increase in mean arterial pressure of approximately 5-15%, and respiration became slower and deeper. A 30-minute interval was allowed between nerve section and DxSO4 injections. At the end of this time, the mean arterial pressure was still approximately 5-15% above pre-section levels. In one rabbit, the response to bradykinin was measured before and after nerve section. The change in mean arterial pressure to 40, 200, and 1000 ng bradykinin were 0, 7, and 19 mm Hg before section and 0, 15, and 40 mm Hg after nerve section. Thus, the response to bradykinin remained intact after nerve section.
In the experiment in which both internal carotid arteries were tied (Figs. 14 and 15), the rabbits first were treated by nerve section, as described above. Clamping of one or both internal carotid arteries produced an immediate increase in mean arterial pressure of about 30%. If we allowed an interval of 60 minutes, mean arterial pressure fell to approximately 10% above the initial levels. For the experiment described in Figures 14 and 15 , 60-minutes elapsed between carotid ligation and rechallenge with serotonin and the DxSO* injection.
For the nitroprusside/bradykinin study ( Fig. 19 ), femoral arterial catheters were placed in the rabbits, under barbiturate anesthetic. The drugs to be tested (serotonin 22 ng, bradykinin 1 fig, or sodium nitroprusside 50 /jg) were injected as a bolus into an ear vein in 0.5 ml of 0.15 M NaG. Each drug was tested in duplicate at each stage of the experiment in four rabbits. After the control studies, the depressor and vagus nerves were in turn identified and cut as described above. After 10 minutes, the drugs were tested. Both carotid arteries then were tied. After 15 minutes, the drugs were tested again.
Statistical Analysis
Paired f-test was used for this analysis.
Miscellaneous
Human deficient plasmas were purchased from George King Biomedical, Inc. Angiotensin-converting enzyme inhibitor (SQ 20881) 
Results
Pathophysiological Consequences of Dextran Sulfate Injection
Dextran sulfate (mol wt 500,000) injection (20 mg/kg / intravenously, given over a 20-second period) had no immediate adverse effect on the rabbit. After a 45-to 60-second interval, there was a slight 265 rise in systemic arterial pressure, followed immediately by a profound decrease in arterial pressure of about 30-40% accompanied by bradycardia (Fig. 1 ). This hypotension was associated with transient irregular respiration and, in some rabbits, mild wheezing, defecation, or micturition. Large waves of peristaltic bowel movements were visible through the abdominal wall. These changes lasted approximately 1 minute. Over the next 5-15 minutes, the arterial pressure returned toward the preinjection values, but never attained those values, remaining at 90-95%. There were no apparent aftereffects, with the exception of a severe tendency to bleed. At lower doses of injected DxSO*, some rabbits became hypotensive and some did not. The response tended to be all-or-nothing. Increasing the amount of DxSO 4 injected did not increase the hypotension.
Blood Cell Changes following DxSO 4 Injection
Platelets
In three separate experiments, intravenous injection of DxSO * (20 mg/kg) was immediately followed by disappearance of between 50 and 90% of the platelets from blood within 5 minutes of DxSO 4 injection. By 60 minutes, platelet counts were returning toward preinjection levels. This is illustrated in Figure 2 , in which 51 Cr platelets were used in a group of three rabbits. Of note is the fact that the level of 51 Cr platelets at 4 hours is approximately the same as the level that would be predicted from the slope of disappearance of 51 Cr if no DxSO * had been injected. Similar results were found when platelets were counted directly in other experiments (data not shown). This implies that platelets were sequestered somewhere in the animal following DxSO 4 injection, but that they returned to the circulation and were not removed and destroyed by 
FIGURE 2. Comparison of changes in blood platelets ("Cr platelets) and neutrophils and monocytes (counted in a counting chamber) from controls and from rabbits that had been injected with DxSO t (20 mg/ kg) which had been depleted of C3 with cobra factor (CoF) (n = 3 rabbits in each group). During the hour preceding DxSOt injection, there was a 4-5% fall in circulating "Cr platelets. The responses were not statistically significantly different (P = 0.13 at 5 minutes) except at the 4-hour point (P = 0.03). Both groups of animals showed an immediate unequivocal decrease in blood platelets following DxSO t injection. By 4 hours after DxSO { injection, the "Cr platelets had returned to the circulation at approximately the predicted level, indicating that extensive platelet lysis had not occurred. The blood neutrophil count fell to 40% of control following DxSO t injection, but by 1 hour after DxSO t injection had rebounded to 340% of initial
values. These changes were prevented by cobra factor treatment (P < 0.05 at both 5 minutes and 1 hour; P > 0.05 at 4 hours), indicating that C3 was necessary for the changes in blood neutrophil count. The apparent fall in blood monocyte count to 46% of control at 5 minutes was prevented by prior treatment with cobra factor. None of the differences were statistically significant. the spleen. In other words, the thrombocytopenia was not due to thrombolysis.
In a parallel experiment in which three rabbits were depleted of C3 by prior injection of cobra factor (see Methods), DxSO4 injection induced a fall of 51 Cr platelets which was not statistically significantly different from that seen in the control rabbits over the first hour (Fig. 2) . These results suggest that the thrombocytopenia was not completely C3 -dependent, although complement activation may have contributed to thrombocytopenia.
Neutrophils
Within 5 minutes of DxSO 4 injection, there was a fall in neutrophil count to 36% of the starting values (Fig. 2 ). This was followed by a neutrophilia of 340% by 60 minutes which persisted until 4 hours after DxSO 4 injection (Fig. 2 ). These changes in neutrophil count were prevented by prior depletion of C3 by cobra factor injection (Fig. 2) . These data suggest that complement activation occurred following DxSO 4 injection and was responsible for the initial neutropenia followed by a rebound neutrophilia.
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Mononudear Cells
The mononuclear cell count (monocytes and lymphocytes) fell by 46% 5 minutes after DxSO 4 injection. This fall was also prevented by prior cobra factor treatment (Fig. 2) .
Basophils
Basophils were counted using a metachromatic stain (Meng et al., 1973) . Two minutes after DxSO 4 injection, the metachromatically stained cells in blood had fallen to 18% of initial levels. By 30 minutes, the level had increased to 84% of starting values (data not shown).
Hematocrit
There was a small rise in hematocrit of 2-3% 5 minutes after DxSO 4 injection (data not shown).
Effect of Depletion of C3 upon DxSO 4 -Induced Hypotension
DxSO 4 is known to activate complement. Therefore, to determine whether the complement system was playing a major role in the hemodynamic changes seen after DxSO 4 injection, three rabbits were depleted of C3 with cobra factor to less than 4% of control levels (see Methods and Fig. 2 ). After DxSO 4 injection, both cobra factor-treated and control rabbits exhibited brisk hypotensive responses which were not significantly different (Fig. 3) . There was therefore no evidence that C3 was essential to mediation of the cardiovascular response to DxSO 4 .
Effect of Depletion of Hageman Factor with Goat Anti-H* IgG
DxS0 4 is known to activate the HF system, and activation of HF in plasma by DxSO 4 leads to bradykinin generation (Kluft, 1978) . Since bradykinin injection in the rabbit can cause bradycardia and hypotension similar to that seen after DxSO 4 administration, studies were performed to examine the possibility that HF-mediated bradykinin formation was responsible for the observed cardiovascular changes. The rabbits were depleted of HF to less than 0.1% of initial circulating HF level by infusion of goat anti HF IgG (see Methods). After DxSO 4 injection, there was a brisk hypotensive response in both rabbits associated with bradycardia similar to that seen in a rabbit receiving control non-immune IgG (Fig. 4) . This implies that the HF was not essential for the cardiovascular response to DxSO 4 injection.
Effect of Inhibition of Angiotensin-Converting Enzyme on DxSCVInduced Hypotension
To investigate further whether bradykinin generated by a different mechanism could be mediating cardiovascular events following DxSO 4 injection, the effect of prevention of bradykinin destruction by FIGURE 3. Changes in mean arterial pressure (MAP) following DxSO t injection (20 mg/kg) in rabbits depleted of C3 with cobra factor (n = 3) and in control animals (n •= 3). After DxSOt injection, there was an initial rise in MAP followed by a fall to approximately 70 and 80% in both the control and cobra factor-treated animals, respectively. These differences were not significantly different. The cardiovascular changes m response to DxSO t were therefore not prevented by prior depletion of C3.
inhibition of kininase II (the angjotensin-coverting enzyme) was studied. SQ 20881 (5 mg/kg) was injected into three rabbits 10 minutes before DxSO 4 injection, (hi parallel studies, this dose of SQ 20881 potentiated bradykinin-induced hypotension more than 10-fold.) The results are shown in Figure 5 . SQ 20881 actually inhibited the DxSO 4 -induced hypotension and bradycardia. The reason for this is not known. However, the result is the opposite of that which would be expected if bradykinin were a mediator of the DxSO 4 -induced cardiovascular effects. These data make it very unlikely that kinin generation was contributing to DxSO 4 -induced hypotension and bradycardia in these experiments. 
Effect of Depletion of Blood Platelets
Depletion of blood platelets to less than 10% of normal with antiplatelet serum (see Methods) prevented the hypotension and bradycardia in response to DxSO 4 injection (Fig. 6 ). These data imply that platelets play an essential role in mediating the response.
Distribution of Blood Platelets after DxSO« Injection
51
Cr-Labeled platelets were used to determine what had happened to the platelets which had disappeared from the blood. Rabbits were injected with a blood marker ( Cr-platelets were circulating prior to study.
Quantification of Platelets in the Lung 2 Minutes after DxSO« Injection
The actual number of platelets trapped in the lung after DxSO 4 injection was calculated from (1) the mean difference in 51 Cr counts between experimental and control rabbits (4265 counts/min 51 Cr/mg lung tissue), (2) the mean total lung weight (11.0 g), and (3) the mean blood platelet count and corresponding 51 Cr level before DxSO 4 injection (3.8 X 10 8 platelets/ml = 2558 counts/min f elCr/ml). Approximately 7.0 X 10 9 more platelets were estimated to be in the DxSO 4 -treated rabbit lungs than in control rabbit lungs. This number corresponds to only 11% of the total number of circulating platelets. Since 50-90% of the platelets disappeared from the circulation after DxSO 4 injection in three separate experiments and the lung seemed to be the only site of platelet accumulation after DxSO 4 injection, this leaves a large number of platelets unaccounted for. This could be explained by platelet lysis, but such an explanation does not seem likely in view of the data shown in Figure 2 , where the level of Cr platelets 4 hours after DxSO 4 injection was close to the predicted value. In other words, there was no evidence for net permanent loss of platelets. An alternative explanation is that increased lung permeability occurs after DxSO 4 injection. The fact that increased permeability did occur was shown by finding increased I-albumin in lungs (6387 ± 1856 counts/min per g in DxSO 4 -treated group compared with 1418 ± 423 counts/min per g in control group, P < 0.05) in addition to intraalveolar hemorrhage immediately after DxSO 4 injection (Fig. 7) . If *Ialbumin was leaking out of the vascular compartment into the lungs after DxSO125 4 injection, then the use of I-albumin as a blood marker would result in falsely low calculated values for platelet trapping in the lung. The calculation that 7 X 10 platelets Circulation Research/Vol. 57, No. 2, August 1985 were trapped in the lung therefore is probably an underestimate.
Ultrastructural Analysis of Lungs after DxSO 4 Injection
Lung tissue was examined ultrastructurally from a control rabbit and rabbits sacrificed 2, 3, and 30 minutes after DxSO 4 injection (see Methods).
In normal rabbit lung (Fig. 7A ), platelets were rarely seen, and, when present, were rod-shaped and contained numerous dense granules. Only an occasional neutrophil was seen.
Within 2 or 3 minutes of DxSO 4 injection, many changes had occurred (Fig. 7 , B and C): The lumina of some capillaries were filled with granular amorphous material which was probably DxSO 4 or a plasma-DxSO 4 mixture. Within this amorphous material were many platelets which were irregularly shaped, contained vacuolar structures, and had fewer dense granules than control platelets. Higher magnification revealed what appeared to be granules in the process of passing into vacuolar structures that were in direct communication with the exterior of the cell (Fig. 8) . In addition to the platelet changes, other types of cells had appeared in the lung (Fig.  7 , B and C). These were (1) numerous neutrophils that were present both in capillaries which did and which did not contain amorphous material, (2) numerous eosinophils, and (3) cells with multilobed nuclei whose cytoplasm contained patchy dense granule-like material. These cells often appeared to lie beside eosinophils (Fig. 7 , B and C) within lung capillaries, and are probably degranulated basophils. Erythrocytes were present in alveolar spaces (Fig.  7C) .
Thirty minutes after DxSO 4 injection (Fig. 7D) , most of the changes noted at 2 and 3 minutes had disappeared. No erythrocytes were seen in alveolae, and no amorphous material was present in capillaries. Neutrophils still were present, but the eosinophils and basophils had disappeared. Many more platelets were present than in normal lung. Some were large (up to half the diameter of an erythrocyte). They were rounded, contained many vacuoleUke structures, and few or no dense granules.
These observations are compatible with the concept that DxSO 4 accumulates in lung capillaries after intravenous injection and remains there for at least 3 minutes. Platelets became trapped and activated in these capillaries. Dense granular contents were released from platelets via an open canalicular system, as has previously been described (White, 1974) . Other circulating cells (neutrophils, eosinophils, and probably also basophils) accumulate in the lung capillaries. There was a leak of erythrocytes out of capillaries into alveolar space. By 30 minutes after DxSO 4 injection, the lung anatomy was returning toward normal with platelets still showing signs of having been activated.
Amount of Histamine and Serotonin Released from Platelets in Lung
Dense granules from rabbit platelets contain histamine and serotonin. The amounts of serotonin and histamine present in rabbit platelets have been measured previously [serotonin 38.5, and histamine 26.2 nmol/mg protein, respectively (Da Prada et al., 1981) ]. With this information, and knowing the number of platelets trapped in the lung 2 minutes after DxSO 4 injection from data described above (7 X 10 9 platelets), and the number of rabbit platelets constituting 1 mg platelet protein [2.2 X 10" platelets/mg protein (personal observation)], it was possible to estimate that approximately 100 jig histamine and 217 /xg serotonin could have been released from these platelets. For the reasons discussed above, the calculated number of platelets trapped in lung may well be an underestimate. On the other hand, not all dense granules were extruded from the trapped platelets. Nevertheless, with these approximate amounts of histamine and serotonin in mind, further studies were performed to determine whether these agents could have caused DxSO 4 -induced hypotension.
Effect of Histamine on the Arterial Pressure of the Rabbit
A biphasic arterial pressure response following bolus histamine injection (100-300 ng, intravenously) was obtained, as has been described previously (Brimblecombe et al., 1974 ). An initial marked hypertensive phase was followed within 30 seconds of histamine injection by a more prolonged hypotensive phase lasting about 4-5 minutes (data not shown). As has also been reported (Carroll et al., 1974) , the initial hypertensive response could be blocked by the Hi antagonist, chlorpheniramine (20 mg/kg) (data not shown), and the hypotensive response could be blocked by the H 2 antagonist, cimetidine (10 mg/kg) (data not shown). However, this pattern of arterial pressure response following bolus histamine injection bore no resemblance to the DxSO 4 -induced hypotensive response. Infusion of 50-200 jig histamine over a 1-minute period instead of as a bolus caused mild hypertension or no change in arterial pressure during the infusion. When the infusion was stopped, mild hypotension occurred (Fig. 9, middle panel) . These arterial pressure changes did not resemble the changes seen after DXSO4 injection. Furthermore, in other studies, infusion or injection into the right ventricle (to bypass the sinus node) also caused hypertension followed by mild hypotension, as described above.
Thus it was not possible to reproduce the DxSO 4 -induced hypotension and bradycardia by histamine injection over a wide dose range, no matter how the histamine was administered.
Effect of Serotonin upon the Systemic Arterial Pressure of the Rabbit
Serotonin injection (22 /ig, intravenously) caused immediate bradycardia and hypotension with a fall in arterial pressure of about 30% (Fig. 10 , panels B and C). This pattern of hypotension and bradycardia was very similar to that caused by DxSO 4 injection. This effect could be inhibited by prior injections of cimetidine (60 mg/kg) (Fig. 10 , panels D and E). Intraarterial injection of serotonin (22 fig) reproducibly produced only a small rise in arterial pressure (Fig. 10, panel A) . Furthermore, injection of serotonin (200 ^g) alone as a 1-minute infusion immediately induced hypotension and bradycardia similar to that seen after injection of DXSO4 (Fig. 9 , top panel), although the duration of the hypotension was slightly less than that observed after DxSO 4 . However, mixing serotonin (200 fig) together with histamine (100 jig) produced a more prolonged hypotensive effect, which was almost identical to that observed after DxSO 4 injection (Fig. 9 , bottom panel). These findings implied that the major agent responsible for hypotension and bradycardia following DxSO 4 injection was serotonin, although histamine probably reduced the immediate hypotension and enhanced the second phase of hypotension. We therefore performed further studies to determine whether serotonin could be the major agent responsible for DxSO 4 -induced hypotension and bradycardia.
Plasma Serotonin Concentration after DxSO 4 Injection
Blood was removed from an intraarterial catheter at 30-second intervals after DxS0 4 injection (Methods). The plasma was immediately separated and frozen for serotonin assay (Methods). The results are shown in Figure 11 . Immediately after DxSO 4 injection, the level of plasma serotonin rose 5-fold 
FIGURE 10. Effect of serotonin (S) injection (22 ng) on the cardiovascular system of a rabbit. Intraarterial injection (panel A) caused a small rise in arterial pressure (the downspike is an injection artifact caused by injecting through the catheter used to monitor arterial pressure). Intravenous injection of serotonin caused bradycardia and hypotension (panel B) which was reproducible (panel Q. Cimetidine (Q injection (60 mg/kg) intravenously had no effect on heart rate or blood pressure (panel D), but it changed the cardiovascular effects normally seen after intravenous injection of serotonin (hypotension and bradycardia) to a small rise in pressure similar to that seen after intraarterial injection (panel E).
and then returned rapidly to baseline values within 3 minutes. Injection of serotonin (22 /zg) doubled the plasma serotonin concentration (Fig. 11) . The mean baseline serotonin concentration was 552 ± 51 ng/ml. From these data it can be estimated that approximately 100-300 ^g of serotonin (equivalent to the content of 3-9 X 10 9 platelets) were released after DxSO 4 injection (assuming a blood volume of 180 ml in a 2.5-kg rabbit). This is in good agreement with the value of 217 ^g of serotonin potentially released from trapped platelets in the lung (see above).
Since the method used for measuring plasma serotonin employed fluorescence of OPT in acidified plasma, it was not entirely specific for serotonin. To confinr. that serotonin had been released into plasma after DXSO4 injection, we analyzed samples (in the absence of OPT) by high pressure liquid chromatography (see Methods). Under these conditions, a peak of fluorescence at 210 run was observed in plasma removed immediately after, but not before, DxSO 4 injection. It corresponded exactly to the peak observed when serotonin alone was analyzed on the same system with respect to both peak size and retention time (data not shown). These data confirm that serotonin appeared in blood immediately after DxSO 4 injections and that this assay was quantitative.
Plasma Histamine Concentration after DxSO 4 Injection
Blood was removed at intervals after DxSO 4 injection, and the plasma was separated and assayed for histamine, as described in Methods. The normal histamine level in rabbit plasma was 8.1 ± 2.9 ng/ ml (n = 7). Within 0.5-1 minute after injection of DxSO 4 the level had risen 7-fold (Fig. 12) . The histamine level returned to normal within 5 minutes of DxSO 4 injection. Injection of histamine (100 /xg), intravenously, in two rabbits yielded values of 333.6 and 342.3 ng/ml at 20 seconds and 6.5 and 24.0 ng/ ml at 60 seconds after histamine injection.
These results confirm that histamine was released after DxSO 4 injection. They emphasize how transient was the rise of measurable histamine in blood. However, the amount of histamine required to produce hemodynamic effects of the magnitude seen after DxSO 4 injection, produced a peak of histamine approximately 6-fold higher than that seen after DxSO 4 injection. This is in contrast to the results with serotonin, described above (Fig. 11) , where the amount of serotonin required to produce hemodynamic effects comparable to those seen after DxSO 4 injection gave a peak amount of serotonin approximately 6-fold lower than that seen after injection. These findings support the concept that the major agent responsible for immediate hypotension following DxSO 4 injection was serotonin, not histamine.
Effect of Inhibitors on Serotonin and DxSO 4 -Induced Hypotension
Ketanserin
The serotonin antagonist ketanserin was tested for its ability to block the hemodynamic effects seen after both DxSO 4 and serotonin injection. The capacity of ketanserin to block serotonin-induced hypotension was variable in different animals. However, in those animals in which ketanserin did inhibit serotonin-induced hypotensin, the DxSO 4 -induced response also was prevented. In those animals in which ketanserin did not inhibit serotonin-induced hypotension, the DxS0 4 response was not prevented (Fig. 13) . No inhibition of the histamine response by ketanserin was seen (data not shown). These results are consistent with mediation of DxSO 4 -induced hypotension by serotonin.
Methysergide
Methysergide, a serotonin antagonist, was also tested as a potential tool for use in these studies. However, methysergide infusion, even at high doses (up to 20 mg/min), failed to prevent serotonininduced hypotension and bradycardia (data not shown). Furthermore, histamine-induced hypotension was enhanced by methysergide infusion (data not shown). Therefore, methysergide could not be used as a serotonin antagonist for these studies.
dmetidine
Cimetidine also was tested as a specific histamine H 2 antagonist for use in these studies, and was used at three doses. In each case, the hypotensive response (measured as the mean arterial pressure) to serotonin (22 ng) and histamine (100 fig) was com-pared before and after cimetidine injection and was expressed as percent of the preinjection value. Finally, in each animal (n = 4), DxSO 4 and cimetidine were injected within a 10-minute period. At a cimetidine dose of 2 mg/kg, the serotonin-hypotensive response was diminished from 47.5 ± 4.7% to 35.3 ± 7.1%, the histamine-hypotensive response was diminished from 14.3 ± 6.3% to 8.5 ± 2.8%, and the DxSO 4 response was 32.5 ± 5.1% (compared to 33.0 ± 2.5%, n = 7, for the control group shown in Fig. 9) . At a cimetidine dose of 12 mg/kg, the serotonin response was diminished from 42.5 ± 3.2% to 20.5 ± 5.3%, P = 0.03, the histaminehypotensive response was diminished from 12.2 ± 5.0% to 3.0 ± 2.3%, P = 0.05, and the DxSO 4 response was 21.5 ± 5.9% (compared with 33.0 ± 2.5%, n = 7, for the control group of rabbits shown in Fig. 9 ). At high doses of cimetidine (60 mg/kg) / the hypotensive response to serotonin injection was completely inhibited in five rabbits, as has been reported previously (Wiggins and Campbell, 1983) , and as illustrated in Figure 10 . This dose of cimetidine also largely prevented the DxSO4-induced hypotension (Fig. 14) . From these studies, we conclude that cimetidine in the rabbit inhibits serotonin-induced hemodynamic changes even at moderate doses (12 mg/kg). The effect of 2 mg/kg of cimetidine was not statistically significant. However, at this lower dose, which should have been sufficient to inhibit H 2 effects, the DxSO 4 response was not inhibited. At the intermediate dose of cimetidine (12 mg/kg)/ the DxSO 4 response was somewhat depressed in parallel with the serotonin response. This result does not rigorously discriminate between serotonin and histamine as the mediator of the response, but is compatible with the concept that serotonin is the major mediator, and strongly supports the concept that serotonin and/or histamine caused the DxSCVinduced hypotension.
Role of Autonomic Nerves in Mediating Serotonin-Induced Hypotension and Bradycardia
Serotonin has been shown to cause bradycardia and hypotension in rabbits primarily via autonomic reflexes (Erspamer, 1966) . A study was therefore performed to determine whether these reflexes were responsible for DxSO4-induced hypotension. Both the vagus and depressor nerves were identified in the neck of rabbits (see Methods). In one group of animals, the nerves were cut. hi the other group (sham-operated), the nerves were left intact. The response of these two groups of animals to intravenous serotonin injection is shown in Figure 15 . Before section, both groups of animals showed a similar hypotensive response to intravenous serotonin (22 ng). After section, this hypotensive response was both delayed and blunted. However, a definite response still was present after nerve section, which might have been caused by a reflex initiated by receptors in the carotid sinus that was left intact in this experiment. Thus, after serotonin injection into a central vein, the time taken to reach the carotid sinus would be longer, thus causing the delayed response. (In other experiments, injection of serotonin directly into the common carotid artery reproducibly caused hypotension and bradycardia). These two groups of rabbits were then injected with DxSO 4 (20 mg/kg). As shown in Figure 16 , the initial marked hypotensive response was prevented by vagus and depressor nerve section. Delayed hypotension did occur 2-3 minutes after DxSO 4 injection. We conclude that vagus and depressor nerve section did partially prevent DxSO 4 -induced hypotension. However, a further experiment was performed to determine whether inhibition of the carotid sinus receptors, in addition to the heart and lung receptors, would completely prevent DxSO4 induced hypotension.
Effect of Carotid Ligation Plus Vagus and Depressor Nerve Section
Two groups of three rabbits were treated as in the previous experiment, except that, in addition to va- gus and depressor nerve section, the carotid arteries on both sides were ligated (see Methods). Since the baroreceptors were left intact, this procedure itself caused an initial 30% rise in mean arterial pressure. However, if the rabbits were left for 60 minutes following the procedure, the systemic arterial pressure fell to within 10% of precarotid ligation values and was stable. Rabbits treated in this way showed an immediate hypotensive response to serotonin injected into the carotid artery above the point of ligation, but they showed a markedly blunted response to intravenous serotonin injection (Fig. 17) . However, the hypotensive response was not prevented completely, and a small response was noted in all animals. This may reflect the effects of other accessible serotonin receptors not excluded by the procedure (see Discussion). However, this maneuver did largely prevent DxSO 4 -induced hypotension (Fig. 18) . A further study was performed to confirm that nerve section and carotid ligation did not prevent vasodilator responses nonspecifically. As shown in Fig. 19 , nerve section diminished the response to serotonin as described above, but did not reduce the response to bradykinin (1 ng) or sodium nitroprusside (50 ^g)-Similarly, carotid ligation in addition to nerve section markedly reduced the serotonin response while leaving the response to bradykinin and sodium nitroprusside intact. The values for presection, post-nerve section, and post-nerve section plus carotid ligation, were, for serotonin, 51.3 ± 14.8, 29.0 ± 3.2, and 14.3 ± 3.2%, for bradykinin were 61.3 ± 10.3, 62.3 ± 10.2, and 57.0 ± 12.7%, and for nitroprusside were 38. 3 ± 13.2, 44.3 ± 9.7, and 47.3 ± 15.9%, respectively (n = 4) .
From these studies on the effect of nerve section and carotid ligation, we conclude that an intact autonomic nervous system was necessary for the hypotension and bradycardia observed following DxSO4 injection.
Discussion
In the experiments described, an anaphylactoid response was induced by intravenous injection into rabbits of the polyanion dextran sulfate (DxSO 4 ). This 'anaphylactoid' response included the following features: hypotension, bradycardia followed by tachycardia, irregular respiration, wheezing, bowel peristalsis with occasional defecation and micturition, and a bleeding tendency. The original purpose of the experiment was to observe the consequences of activation of Hageman factor in vivo by a substance known to activate the HF system, namely dextran sulfate (Kluft, 1978; Ulevitch and Johnston, 1980) . Hageman factor activation caused by DxSO 4 injection would be expected to result in kinin generation with consequent hypotension (Cochrane and Griffin, 1982) . In fact, although the Hageman factor system was activated in these experiments (as judged by proteolysis of circulating radiolabeled rabbit Hageman factor, prekallikrein and high molecu- lar weight kininogen (data not shown), HF system activation was not responsible for the observed changes in systemic arterial pressure and heart rate. This was demonstrated by finding that Hageman factor depletion did not prevent the response, and inhibition of kininase II (by SQ20881) did not enhance the hypotension. Therefore, a series of studies was performed to determine the mediators involved in DxSCVinduced hypotension. Dextran sulfate has been reported to activate the alternative pathway of complement (Burger et al., 1975) . In addition, in rabbits, cobra factor injection has been reported to cause immediate hypotension similar to that seen after injection of DxSO 4 (Ulevitch and Cochrane, 1977) . Furthermore, in the studies described here, DxSO 4 injection caused a 10% fall in antigenic C3 levels in blood, and this was accompanied by blood neutropenia (Fig. 2) in association with neutrophil margination in lung capillaries (Fig. 7) . This sequence of events is well described as a consequence of C5a production or injection in vivo (Jacob, 1981) . Further evidence that complement activation did indeed occur after DxSO 4 injection is provided by the finding that, when rabbits were depleted of C3 using cobra factor, neutropenia was prevented, as was the characteristic rebound neutrophilia that followed DxSO 4 injection (Fig. 2) . However, in these same experiments, in spite of the above evidence for complement activation, C3 depletion did not prevent DxSO 4 -induced hypotension and bradycardia (Fig. 3) . A complement-independent mechanism must therefore have been responsible.
Platelet depletion has been shown to prevent the hypotension caused by IgE-induced anaphylaxis in the rabbit (Benveniste et al., 1972; Pinckard et al., 1977; McManus et al., 1979) . In the studies described here, platelet depletion similarly prevented DxSO 4 -induced hypotension and bradycardia (Fig.  6) . Furthermore, following DxSO 4 injection, platelets were shown to disappear from blood ( Fig. 2) and appear in lung (Table 1) , where ultrastructural studies 2 minutes after DxSO 4 injection showed them to be aggregated and in the process of degranulating (Figs. 7 and 8) .
But how might platelet activation in the lung cause hypotension? Rabbit platelets contain both histamine and serotonin in their dense granules (Da Prada et al., 1981) . The fact that cimetidine infusion at high doses prevented DxSO 4 -induced hypotension pointed toward histamine as the important mediator. However, when histamine itself was infused or injected intravenously, or into the right ventricle, the predominant result was either no change in blood pressure or immediate hypertension with tachycardia followed by a mild hypotensive phase (Fig. 9) , as has been previously described in the rabbit (Brimblecombe et al., 1974; Carroll et al., 1974) . It therefore was not possible to account for the DxSO 4 -induced hypotension and bradycardia simply in terms of histamine release from platelets (or from the basophils which disappeared from the blood and appeared in degranulated form in the lung following DxSO 4 injection). In contrast, serotonin injection reproduced the immediate hypotension and bradycardia seen following DxSO 4 injection ( Fig. 10) , although the hypotension was less prolonged than that seen after DxSO 4 injection, even when high doses of serotonin were injected (300 g). That histamine did probably contribute to the DxSO 4 -induced hemodynamic changes was suggested by the finding that a combination of histamine (100 Mg) and serotonin (200 fig) infused over 1 minute appeared to reproduce more closely both the extent and duration of the events seen after DxSO 4 injection (Fig. 9) . In quantitative terms, enough platelets accumulated in lung following DxSO 4 injection to release about 100 j*g of histamine and 200 ng of serotonin. Direct measurement of serotonin in blood following DxSO 4 injection confirmed that 5-10 times more serotonin could be detected after DxSO 4 injection than was detected after intravenous injection of 22 fig serotonin (sufficient to cause hypotension and bradycardia). In contrast, direct measurement of histamine in blood following DxSO 4 injection showed that 5-10 times less histamine could be detected after DxSO 4 injection than was detected after injection of 100 Mg of histamine (sufficient to cause only mild hypotension). These independent measurements confirmed that the amount of serotonin released was adequate to cause the observed hypoten-sion and bradycardia. In contrast, the amount of histamine measured in blood probably was insufficient to cause the observed hemodynamic effects.
Ketanserin, a serotonin antagonist, did inhibit the DxSO 4 -induced hypotension, but only in those rabbits in which it inhibited the serotonin-induced response. These findings are compatible with the concept that the major cause of DxSO 4 -induced hypotension was serotonin. This effect of a specific serotonin antagonist in preventing dextran-induced hypotension is similar to that reported in rats by Berstad (1981) . However, the effect of serotonin antagonists, such as ketanserin, might occur by inhibiting platelet aggregation in blood vessels rather than by inhibiting the effect of released serotonin on tissue receptors. This concept recently has been emphasized by Meuleman et al. (1983) and Bergqvist et al. (1983) .
The finding that cimetidine inhibited DxSO 4 -induced hypotension initially pointed toward histamine as the important mediator. However, at the doses used, cimetidine also prevented the serotonininduced cardiovascular changes (Fig. 10) , as has been reported elsewhere (Wiggins and Campbell, 1983) . This inhibition of hypotension by cimetidine therefore did not discriminate between histamine and serotonin in these experiments, although it did support the concept that serotonin and/or histamine was the mediator.
Further evidence that serotin was the major factor operative in causing DxSO 4 -induced hypotension was the finding that DxSO 4 -induced hypotension could be diminished by section of the vagus and depressor nerves, and could be prevented by carotid ligation in addition to nerve section. That this was not a nonspecific response to this maneuver was shown by demonstrating that the responses to bradykinin and sodium nitroprusside remained intact while the response to serotonin was lost. This again supported the concept that serotonin-mediated autonomic reflexes were largely responsible for the observed hemodynamic changes. Taken together, these results all point toward a serotonin-mediated chemoreflex as the major cause of DxSO 4 -induced hypotension. Histamine release undoubtedly occurred after DxSO 4 injection, and certainly contributed to the prolongation of hypotension. However, it was not the major factor.
The chemoreflexes by which serotonin induces hypotension and bradycardia were originally identified by Bezold and Hirt in 1867 and were further analyzed by Jarish and Richter (1939) using veratrum alkaloids. Dawson and Comroe (1954) defined three separate chemoreflexes in the heart and lungs. These were (1) a coronary chemoreflex, (2) a pulmonary depressor chemoreflex, and (3) a pulmonary respiratory chemoreflex. The afferent limb of these reflexes begins with chemoreceptors in the lungs, heart, carotid sinus, and probably also the nodose ganglion (Jacobs and Comroe, 1971) . Signals travel in the vagus nerve, and depressor nerve in the rabbit (Winton and Bayliss, 1955) , to the autonomic nerve centers in the brain. The efferent limb appears to take the form of a general increase in vagal tone and a decrease in sympathetic tone, but there are also more localized organ effects (e.g., on lungs or cardiovascular system) depending upon the site of receptor stimulation (Erspamer, 1966) . The results of this change in autonomic climate almost certainly affect every organ. In this study, heart rate and blood pressure were measured. Both decreased markedly. Similar responses to serotonin injection in rabbits and cats have previously been documented (Erspamer, 1966) . In other studies, reflex vasodilation due to decreased sympathetic activity has been observed in the isolated hind limb, liver, kidney, intestine, spleen, and retina (Erspamer, 1966) . A recent review by Mecca and Webb (1984) suggests that the vasodilator response to serotonin may be the result of a combination of neural and direct vascular events. However, the results from this study suggest that the neural events predominate, at least with respect to systemic blood pressure changes induced by intravenous injection of serotonin in the rabbit.
Increased parasympathetic activity can cause smooth muscle contraction in the gut, bladder, and in bronchioles, and might well have accounted for or contributed to the noncardiovascular changes observed in rabbits following DxSO 4 injection (wheezing, micturition, defecation), although anaphylatoxins (C3a, C5a), together with histamine release, bradykinin generation, or direct effects of serotonin, might also have contributed to these events. It is possible that the observed irregular respiration was also due to the chemoreflex, since this is a regular feature of the serotonin-induced reflex (Erspamer, 1966) .
The mechanism by which DxSO 4 caused platelet activation in the lung has not been worked out, although DxSO 4 has previously been observed to cause platelet aggregation (Walton, 1953; Brossmer and Pfleiderer, 1966; Tiffany and Penner, 1981) . In preliminary studies, [ 3 H]serotonin was not released from platelet-rich plasma; neither was it released from washed plasma-free platelets when incubated in the presence of DxSO 4 . These findings imply that some mechanism other than a direct interaction between DxSO 4 and platelets was taking place. We observed that blood basophil counts diminished immediately after DxSO 4 injection, and that cells which were probably degranulated basophils appeared in lung at the same time. It is therefore possible that DxSO 4 injection resulted in basophil activation with consequent release of platelet-activating factor (AGEPC). If so, the sequence of events would be similar, but not as profound, as those observed to occur in the model of IgE anaphylaxis in the rabbit (Benveniste et al., 1972; Pinckard et al., 1977; McManus et al., 1979) . No evidence is provided to show that DxSO 4 does interact directly with basophils, although such an interaction might occur either via a charge effect or, as has recently been suggested, by a simple osmotic effect (Findlay et al., 1981) . An alternative explanation is that rabbits could have natural antibodies against dexrrans (Palosvo and Milgrom, 1981) , or that DxSO 4 -immunoglobulin interactions might trigger platelet activation (Levy et al., 1981) . Activation of complement by DxSQi may also have contributed to platelet activation and thrombocytopenia as well as neutropenia (Ulevitch and Cochrane, 1977) . However, this mechanism cannot totally account for the plateletinduced hypotension, since C3 depletion did not prevent DxSO.»-induced hypotension.
Dextran sulfates have been studied as synthetic heparin-like molecules (Walton, 1954) , and the severe bleeding tendency induced by DxSO« in these studies probably was due to this heparin-like effect.
As has been emphasized by this discussion, DxSC>4 injection results in activation of many mediator systems. The question addressed in this study was which system caused the observed cardiovascular changes? Evidence is provided that platelet activation in the lungs caused bradycardia and hypotension by means of powerful autonomic reflexes activated by serotonin as outlined below.
Platelet-activating substances 
I
Effects on organs (Blood flow, smooth muscle, heart rate, etc.)
